Cardiff Lexington, a holding company focused on acquiring business primarily in the healthcare sector, filed on Monday with the SEC to raise up to $7 million in an initial public offering. Cardiff Lexington originally filed for an IPO in July 2023, but later withdrew its filing in March 2025. The company is currently trading on the OTC under the symbol “CDIX”.
Cardiff Lexington is a healthcare-focused holding company that acquires and builds middle-market niche clinics, with an emphasis on orthopedics, spine care, and pain management. Its operating subsidiaries include Nova, which operates regional specialty and ancillary care facilities in Florida and Georgia serving traumatic injury patients, and Edge View, a real estate subsidiary holding undeveloped land in Idaho.
The Las Vegas, NV-based company was founded in 1986 and booked $12 million in revenue for the 12 months ended September 30, 2025. It plans to list on the Nasdaq under the symbol CDIX. R.F. Lafferty & Co. is the sole bookrunner on the deal. No pricing terms were disclosed.
